Supriya Lifescience Limited (SUPRIYA) Share Analysis
NSE · Healthcare · Pharmaceuticals
Supriya Lifescience Limited (NSE: SUPRIYA) is an Indian listed company in the Pharmaceuticals sector and a constituent of NIFTY Microcap 250. As of 14 Nov 2026, the share price was ₹632.00, P/E 28.6, ROE 19.1%.
Get the AI verdict on SUPRIYA: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
SUPRIYA chart with trendlines
Is SUPRIYA a buy right now?
Sign in free for the AI verdict with entry zone, targets and stop-loss.
About Supriya Lifescience Limited
Stored fundamentals as of 14 Nov 2026 — not a live quote. Signed-in analysis uses same-day data.
SUPRIYA key facts
| Price and valuation | |
|---|---|
| Share price | ₹632.00 |
| Market cap | ₹5,087 Cr |
| P/E ratio | 28.6 |
| P/B ratio | 4.1 |
| EPS | ₹22.01 |
| Book value per share | ₹154.00 |
| Dividend yield | 0.16% |
| 52-week range | |
| 52-week high | ₹1,085.00 |
| 52-week low | ₹545.50 |
| Face value | ₹2.00 |
| Shareholding pattern | |
| Promoters | 68.3% |
| FIIs | 6.45% |
| DIIs | 5.47% |
| Public | 19.8% |
Index membership: NIFTY Microcap 250.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.